Exosens (LON:0EXO)
London · Delayed Price · Currency is GBP · Price in EUR 45.85
+0.60 (1.33%)
At close: Oct 10, 2025
Exosens Revenue
Exosens had revenue of 224.52M EUR in the half year ending June 30, 2025, with 79.61% growth. This brings the company's revenue in the last twelve months to 431.70M, up 22.05% year-over-year. In the year 2024, Exosens had annual revenue of 394.08M with 35.04% growth.
Revenue (ttm)
431.70M EUR
Revenue Growth
+22.05%
P/S Ratio
5.19
Revenue / Employee
308.14K EUR
Employees
1,401
Market Cap
1.92B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 394.08M | 102.26M | 35.04% |
| Dec 31, 2023 | 291.82M | 91.07M | 45.36% |
| Dec 31, 2022 | 200.75M | 34.58M | 20.81% |
| Dec 31, 2021 | 166.17M | 16.31M | 10.88% |
| Dec 31, 2020 | 149.86M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 41.24B |
| HSBC Holdings | 41.03B |
| Shell | 198.54B |
| Unilever | 51.24B |
| Rolls-Royce Holdings | 19.54B |
| Rio Tinto Group | 39.22B |
| British American Tobacco p.l.c. | 25.60B |
| GSK plc | 31.63B |
Exosens News
- 1 day ago - Theon International To Acquire 9.8% Stake In Exosens For EUR 268.7 Mln - Nasdaq
- 5 months ago - Exosens reaffirms 2024 outlook as NATO demand lifts sales - Seeking Alpha
- 6 months ago - Exosens: Spectral And Imaging Opportunity With Attractive End Markets - Seeking Alpha